Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Qrons Inc (OP:QRON)

0.1360 UNCHANGED
Streaming Delayed Price Updated: 11:35 AM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1360
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1360
Today's Range 0.1360 - 0.1360
52wk Range 0.1360 - 0.1915
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
First Person and Qrons Complete Merger, Creating a Publicly Traded Leader in Cognitive Wellness & Functional Beverages
Via ACCESS Newswire
Qrons Announces the Addition of Professor Shiri Navon-Venezia to its Scientific Advisory Board to Beef up its Team, as Part of its New Sepsis Research Program
Via ACCESSWIRE

Performance

YTD
-21.4%
-21.4%
1 Month
-9.3%
-9.3%
3 Month
-16.0%
-16.0%
6 Month
-15.5%
-15.5%
1 Year
-12.9%
-12.9%

More News

Read More
Qrons Announces Launch of its New Website in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
Via ACCESSWIRE
Qrons Announces the Filing of a Provisional Patent Application in Furtherance of its Neuronal and Infectious Disease Treatments Development, Including Sepsis
Via ACCESSWIRE
Qrons Announces the Signing of a License Agreement Term Sheet as Part of New Research Program to Experiment and Commercialize the Therapeutic Effect of Certain Tellurium Based Compounds on Antibiotic Resistance Bacterial Infections, Sepsis and Traumatic
Via ACCESSWIRE
Qrons files U.S. National Phase of its Patent Application in Furtherance of its QS200 Product Candidate for Therapeutic Polypseudorotaxane Hydrogels
Via ACCESSWIRE
Qrons Announces Engagement of Israeli Intellectual Property Law Firm IPK to Develop Roadmap for Its New Product Line
Via ACCESSWIRE
Qrons Announces a New Pre-Clinical Research Program to Test the Efficacy of Tellurium Based Compounds, in Combination with its QS200(TM) Product Candidate or Independently, in Treating Diffused Axonal Injuries and Antibiotic Resistant Bacteria and Sepsis
Via ACCESSWIRE
Qrons Announces Filing Of Provisional Patent Application In Furtherance Of Its QS200 Product Candidate
From Qrons Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Qrons Announces Effectiveness of Its Post-Effective Amendment to Its Registration Statement
From Qrons Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
Qrons Announces U.S. Patent Office Grants Dartmouth College 3D Printing Patent Forming Basis of License Agreement with Qrons
From Qrons Inc.
Via AccessWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is Qrons Inc publicly traded?
Yes, Qrons Inc is publicly traded.
What exchange does Qrons Inc trade on?
Qrons Inc trades on the OTC Traded
What is the ticker symbol for Qrons Inc?
The ticker symbol for Qrons Inc is QRON on the OTC Traded
What is the current price of Qrons Inc?
The current price of Qrons Inc is 0.1360
When was Qrons Inc last traded?
The last trade of Qrons Inc was at 05/12/25 11:35 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.